ClinicalTrials.gg
CompletedNCT00241605Updated Mar 21, 2018

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

A Phase 4 interventional study of rosiglitazone/metformin in Diabetes Mellitus, Type 2, sponsored by GlaxoSmithKline. Completed at 91 sites in Canada. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-03-21.

Sponsored by GlaxoSmithKline · Phase 4, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 52 studies testing rosiglitazone in Diabetes Mellitus, Type 2 — none open to participants now, none under way, none of them phase 3. Rosiglitazone · Diabetes Mellitus, Type 2.

Enrollment
9th of 51
600 · median 149
Started
2003
with 5 others
Phase 4
21 of 52
none open now
Registered
14th of 52
by date
Lead sponsor
22 of 52
GlaxoSmithKline

Among the 52 studies testing rosiglitazone in Diabetes Mellitus, Type 2, this one is the 9th largest by enrollment of the 51 interventional ones that give a count, is one of 6 that started in 2003, is one of 21 in phase 4, and was the 14th registered.

Diabetes Mellitus, Type 2

10,396 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

None of the 52 studies testing rosiglitazone in Diabetes Mellitus, Type 2 is open now. The open studies under Diabetes Mellitus, Type 2, anywhere →

About rosiglitazone

Rosiglitazone: first FDA approval 1999 (AVANDIA), first EMA approval 2000. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 880 Diabetes Mellitus, Type 2 studies recruiting now, 374 (43%) set no upper age limit and 381 (43%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 52 studies testing rosiglitazone in Diabetes Mellitus, Type 2 as a file.
02

Study summary

This 48-week study will compare AVANDAMET vs. Metformin monotherapy for blood glucose control in patients with Type 2 Diabetes Mellitus.

03

Conditions studied

  • Diabetes Mellitus, Type 2

Keywords

  • Metformin
  • AVANDAMET
  • Type 2 diabetes
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between 18 and 75 years of age with Type 2 Diabetes Mellitus and are currently on metformin monotherapy for glycemic control (100mg daily for at least 3 months prior to screening).
  • Patients must have stopped previous treatment with thiazolidinediones or other anti-diabetic agents at least 3 months prior to screening.
  • Women must be , surgically sterile or using acceptable measures.

Exclusion criteria

Exclusion Criteria:

  • Prior history of hepatocellular reaction to or severe edema associated with the use of thiazolidinediones.
  • Have a known to thiazolidinediones or biguanides.
  • Currently using insulin or any oral anti-diabetic agent other than metformin.
  • History of metabolic acidosis.
  • History of substance abuse.
  • Have active cancer other than localized squamous or basal cell carcinoma.
  • Chronic disease requiring treatment with .
  • Other criteria will be evaluated at the screening visit.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
600 participants

Interventions

06

What researchers measure

Primary outcomes

  1. Change from baseline in HbA1c at week 48.

Secondary outcomes

  1. Change from baseline in FPG at week 48. Time to glycemic control. Change from baseline in C-peptide and insulin at week 48.

07

Study locations

91 sites
  • GSK Investigational Site
    Calgary, Alberta T1Y 3R6, Canada
  • GSK Investigational Site
    Calgary, Alberta T1Y 6J2, Canada
  • GSK Investigational Site
    Calgary, Alberta T2A 0P9, Canada
  • GSK Investigational Site
    Calgary, Alberta T2L 2V9, Canada
  • GSK Investigational Site
    Calgary, Alberta T3B 0M3, Canada
  • GSK Investigational Site
    Calgary, Alberta T3E 0C5, Canada
  • GSK Investigational Site
    Calgary, Alberta T3E 7C4, Canada
  • GSK Investigational Site
    Edmonton, Alberta T5A 4L8, Canada
  • GSK Investigational Site
    Edmonton, Alberta T6L 6K3, Canada
  • GSK Investigational Site
    Medicine Hat, Alberta T1A 6N9, Canada
  • GSK Investigational Site
    Aldergrove, British Columbia V4W 3L6, Canada
  • GSK Investigational Site
    Kelowna, British Columbia V1Y 3G8, Canada
  • GSK Investigational Site
    Vancouver, British Columbia V5P 3T7, Canada
  • GSK Investigational Site
    Vancouver, British Columbia V5X 3T5, Canada
  • GSK Investigational Site
    Vancouver, British Columbia V7N 4M2, Canada
  • GSK Investigational Site
    Winnipeg, Manitoba R2H 0R8, Canada
  • GSK Investigational Site
    Winnipeg, Manitoba R2J 4A7, Canada
  • GSK Investigational Site
    Winnipeg, Manitoba R3A 1M3, Canada
  • GSK Investigational Site
    Fredericton, New Brunswick E5L 1S1, Canada
  • GSK Investigational Site
    Houston, New Brunswick E6E 1H1, Canada
  • GSK Investigational Site
    Neguac, New Brunswick E9G 4H3, Canada
  • GSK Investigational Site
    Bay Roberts, Newfoundland and Labrador A0A 1G0, Canada
  • GSK Investigational Site
    Carbonear, Newfoundland and Labrador A1Y 1C4, Canada
  • GSK Investigational Site
    Saint John's, Newfoundland and Labrador A1A 3R5, Canada
  • GSK Investigational Site
    Saint John's, Newfoundland and Labrador A1B 2X2, Canada
  • GSK Investigational Site
    Dartmouth, Nova Scotia B2W 2S8, Canada
  • GSK Investigational Site
    Halifax, Nova Scotia B3M 3W8, Canada
  • GSK Investigational Site
    Truro, Nova Scotia B2N 1L2, Canada
  • GSK Investigational Site
    Upper Tantallon, Nova Scotia B3Z 4R4, Canada
  • GSK Investigational Site
    Ajax, Ontario L1S 6N2, Canada
  • GSK Investigational Site
    Brampton, Ontario L6T 3T1, Canada
  • GSK Investigational Site
    Brampton, Ontario L6T 4S5, Canada
  • GSK Investigational Site
    Burlington, Ontario L7M 4Y1, Canada
  • GSK Investigational Site
    Cambridge, Ontario N3C 1Z3, Canada
  • GSK Investigational Site
    Fort Erie, Ontario L2A 1Z3, Canada
  • GSK Investigational Site
    Hamilton, Ontario L8L 5G8, Canada
  • GSK Investigational Site
    Innisfil, Ontario L9S 1L2, Canada
  • GSK Investigational Site
    Kingston, Ontario K7M 1W9, Canada
  • GSK Investigational Site
    London, Ontario N5Y 3J8, Canada
  • GSK Investigational Site
    London, Ontario N6P 1A9, Canada
  • GSK Investigational Site
    Mississauga, Ontario L5B 3A8, Canada
  • GSK Investigational Site
    Mississauga, Ontario L5B 4A9, Canada
  • GSK Investigational Site
    North York, Ontario M3M 3E5, Canada
  • GSK Investigational Site
    Oakville, Ontario L6L 2X4, Canada
  • GSK Investigational Site
    Oshawa, Ontario L1H 1C2, Canada
  • GSK Investigational Site
    Ottawa, Ontario K2G 6E2, Canada
  • GSK Investigational Site
    Peterborough, Ontario K9H 1T6, Canada
  • GSK Investigational Site
    Rexdale, Ontario M9V 4B9, Canada
  • GSK Investigational Site
    Richmond Hill, Ontario L4C 2N9, Canada
  • GSK Investigational Site
    Scarborough, Ontario M1J 2E5, Canada
  • GSK Investigational Site
    Scarborough, Ontario M1R 1R9, Canada
  • GSK Investigational Site
    Smiths Falls, Ontario K7A 2H6, Canada
  • GSK Investigational Site
    Sutton, Ontario L0E 1R0, Canada
  • GSK Investigational Site
    Toronto, Ontario M2M 4J5, Canada
  • GSK Investigational Site
    Toronto, Ontario M5G 1E2, Canada
  • GSK Investigational Site
    Windsor, Ontario B0N 2T0, Canada
  • GSK Investigational Site
    Woodbridge, Ontario L4L 8E2, Canada
  • GSK Investigational Site
    Woodstock, Ontario E7M 1H1, Canada
  • GSK Investigational Site
    Woodstock, Ontario N4S 4H4, Canada
  • GSK Investigational Site
    Brossard, Quebec J4Z 2K9, Canada
  • GSK Investigational Site
    Charlesbourg, Quebec G1G 4A2, Canada
  • GSK Investigational Site
    Charlesbourg, Quebec G1H 6P2, Canada
  • GSK Investigational Site
    Chateauguay, Quebec J6K 3A9, Canada
  • GSK Investigational Site
    Courcelette, Quebec G0A 1R1, Canada
  • GSK Investigational Site
    Cowansville, Quebec J2K 2X9, Canada
  • GSK Investigational Site
    Hull, Quebec J8Y 2E2, Canada
  • GSK Investigational Site
    Lambton, Quebec G0M 1H0, Canada
  • GSK Investigational Site
    Lle Perrot, Quebec H8Y 3J2, Canada
  • GSK Investigational Site
    Longueuil, Quebec J4J 3X5, Canada
  • GSK Investigational Site
    Longueuil, Quebec J4N 1E1, Canada
  • GSK Investigational Site
    Longueuil, Quebec J4N 1L6, Canada
  • GSK Investigational Site
    Montreal, Quebec H1M 2M1, Canada
  • GSK Investigational Site
    Montreal, Quebec H4N 2W2, Canada
  • GSK Investigational Site
    Pierrefonds, Quebec H8Y 3J2, Canada
  • GSK Investigational Site
    Pointe-Claire, Quebec H9R 3J1, Canada
  • GSK Investigational Site
    Richelieu, Quebec J3L 4W6, Canada
  • GSK Investigational Site
    Saint Charles Borromee, Quebec J6E 5A9, Canada
  • GSK Investigational Site
    Saint Leonard, Quebec H1S 3A9, Canada
  • GSK Investigational Site
    Saint-Jean sur Richelieu, Quebec J2X 2B2, Canada
  • GSK Investigational Site
    Sainte Anne De Bellevue, Quebec H9X 1M2, Canada
  • GSK Investigational Site
    Sainte Catherine, Quebec J0L 1E0, Canada
  • GSK Investigational Site
    Sainte-Foy, Quebec G1V 1V6, Canada
  • GSK Investigational Site
    Sainte-Henri De Levis, Quebec G0R 3E0, Canada
  • GSK Investigational Site
    Salaberry-De-Valleyfield, Quebec J6S 4Z5, Canada
  • GSK Investigational Site
    Thetford Mines, Quebec G6G 6H1, Canada
  • GSK Investigational Site
    Vaudreuil, Quebec J7V 8P9, Canada
  • GSK Investigational Site
    Ville Lasalle, Quebec H8N 1X9, Canada
  • GSK Investigational Site
    Saskatoon, Saskatchewan S7K 1N4, Canada
  • GSK Investigational Site
    Saskatoon, Saskatchewan S7L 2W1, Canada
  • GSK Investigational Site
    Saskatoon, Saskatchewan S7M 0Z6, Canada
  • GSK Investigational Site
    Québec, G1N 1E1, Canada
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2003, a primary completion of Dec 2005 and a completion of Dec 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2005
First posted
Oct 19, 2005
Start
Jun 25, 2003
Primary completionActual
Dec 1, 2005
CompletionActual
Dec 16, 2005
Last update
Mar 21, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00241605
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Oct 19, 2005
Start date
Jun 25, 2003
Primary completion
Dec 1, 2005
Completion
Dec 16, 2005
Last update
Mar 21, 2018

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Rosiglitazone · Metformin

Start the discussion